Men are 50 percent more likely to die from cancer than women, according to new global statistics.
Data published by Cancer Research UK shows more than 4.6 million men die from the disease every year across the globe.
This compares to around 3.5 million women who die from the disease. Central and eastern Europe are the regions where men are most likely to die compared to women, whereas East Africa has the highest death rates for women.It is one of the few regions where rates for women are higher than for men.
In the UK, there is also a stark difference, previously reported, which shows men are 30 percent more likely to die than women.There are 126.05 cancer deaths per 100,000 men in the UK, compared to 97.28 per 100,000 women.
This is one of the lowest differences seen in Europe but still represents a sizeable inequality. The four biggest cancer killers worldwide are of the lung, liver, stomach and bowel.
A cancer scientist has called for more research into cancer after figures showed a rise in the number of people diagnosed with the disease.
These figures reinforce the vital need for more research to better prevent, treat and cure cancer.
As the population ages, more people than ever before will be told: 'you have cancer'.
Research is the only way we'll be able to reduce the devastating impact of the disease.
One day we will beat cancer. The more research we do, the sooner that day will come.
The number of people suffering from cancer has soared since the 1970s, a leading health charity has warned.
According to data released by Cancer Research UK:
- In 1975 around 295 of every 100,000 people were diagnosed with some form of cancer.
- This number rose to almost 400 by 2011.
- Cancer Research blamed an ageing population and lifestyle factors, like excessive drinking or being overweight for the rise.
- While the rates are going up, the number of people surviving the disease is also on the rise.
- In the 1970s just 23% of cancer patients survived for 10 years, this climbed to 46% in 2007.
The number of people diagnosed with some form of cancer reached almost a third of a million in 2011, Cancer Research have said.
More than 330,000 people were found to have the disease where as ten years ago 283,000 were diagnosed, the health charity said.
The charity said that the rates of diagnosis have soared by more than a third since the mid 1970s.
Britain's ageing population was one of the reasons behind the rise in cancer rates, according to the charity.
The overwhelming majority of cancer patients would like doctors to check their symptoms much sooner than they currently do, research suggests.
At least 88% of the 3,649 people who were quizzed by scientists from Bristol University, the University of Exeter Medical School and the University of Cambridge, said they wanted doctors to investigate their symptoms further.
The participants, all over 40, said they wanted further tests done even if there was only a 1% chance of having cancer.
There are no fixed thresholds in the UK, but in practice, the National Institute for Health and Care Excellence (NICE) guidelines suggest patients need to have symptoms which indicate a five per cent risk or higher before further tests for most cancers are carried out.
Dr Jonathan Banks, of Bristol University, said: "This large study provides a clear and comprehensive account of public preference for investigation for cancer."
Medical charities have pinpointed two main reasons why Britain is seen to be lagging behind many other European countries in terms of surviving cancer.
Charities blame late diagnosis and a lack of urgency when it comes to introducing new technology.
A new genetic test has been developed that can distinguish the most aggressive forms of prostate cancer.
The test will help doctors tell apart slow-growing and aggressive cancers, enabling them to respond with the most appropriate treatments.
One of the biggest problems involved in treating prostate cancer is knowing what kind of disease a patient has. The new Prolaris test measures the activity of genes that drive cell division and provides a Cell Cycle Progression (CCP) score.
A one unit increase in CCP score was found roughly to double the risk of prostate cancer death or recurrence. The test should eventually mean that doctors will not have to "overtreat" patients with strong, debilitating drugs. Professor Jack Cuzick, the study author from University of London said:
"Over-treatment of prostate cancer is a serious issue so it's essential that we have an accurate way of spotting those cancers that pose an immediate risk. For patients with slow-growing tumours, it's far safer and kinder to watch and wait - only acting if the situation starts to change.
"We've shown this test is accurate at telling apart these two different tumour types at many different stages of treatment. [...]
"We want to try and shorten the time it takes to get the results and establish how frequently the test needs to be done in order to be most effective at spotting any changes."
Early diagnosis and screening is a crucial tool in the fight against cancer and makes a significant difference to survival rates of all types of cancer, the chief executive of Cancer Research UK said.
In an interview with Science and Medical Editor Lawrence McGinty, Harpal Kumar said:
"Early diagnosis is incredibly important for cancer, and it is true that it is important across just about every type of cancer.
"We know that for the vast majority of cases, the earlier we detect it, the greater the chances of successful treatment, and often for the patient, must less gruelling treatment, so it really can make an enormous difference."
The chances of developing and surviving cancer vary considerably depending on where you live.Read the full story ›